Replicor Secures $180M Series C to Expand RNA Amplification Platform Beyond Hepatitis B 2 years ago AnaIn Pharma Industry UpdatesTop StoriesVenture Capital
FDA Grants RMAT Designation to ExoGene’s Exosome-Based Gene Therapy for ALS 2 years ago AnaIn FDA ApprovalsInvestmentsPharma Industry Updates
mRNA-4157/V940 Shows Durable Response in Melanoma: Moderna and Merck’s Cancer Vaccine Hits Key Milestone 2 years ago AnaIn Clinical TrialsPharma Industry Updates
